Approval for the abbott axsym antibody to hcv.  The device is indicated for the qualitative detection of anti-hcv recombinant proteins in human serum or plasma (potassium edta, sodium edta, sodium heparin, lithium heparin, sodium citrate, and potassium oxalate).